Aiosyn

Aiosyn develops computational pathology software that integrates deep learning algorithms into standard clinical and research workflows. The company provides tools for automated quality control of digital slides, mitosis counting for breast cancer grading, and a platform for quantifying kidney lesion scores. Its products serve pathology laboratories, CROs, and biopharma companies to assist in clinical diagnostics and accelerate drug development.